Your browser doesn't support javascript.
loading
Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312).
Katakami, Nobuyuki; Nishimura, Takashi; Hidaka, Yu; Hata, Akito; Nishino, Kazumi; Mori, Masahide; Hirashima, Tomonori; Takase, Naoto; Kaneda, Toshihiko; Ohnishi, Hisashi; Morita, Satoshi; Hatachi, Yukimasa.
Afiliación
  • Katakami N; Takarazuka City Hospital, Japan; Kobe City Medical Center General Hospital, Japan. Electronic address: nkatakami1954@gmail.com.
  • Nishimura T; Kyoto Katsura Hospital, Japan.
  • Hidaka Y; Kyoto University School of Medicine, Japan.
  • Hata A; Kobe Minimally Invasive Cancer Center, Japan; Kobe City Medical Center General Hospital, Japan.
  • Nishino K; Osaka International Cancer Institute, Japan.
  • Mori M; National Hospital Organization Osaka Toneyama Medical Center, Japan.
  • Hirashima T; Osaka Habikino Medical Center, Japan.
  • Takase N; Takarazuka City Hospital, Japan.
  • Kaneda T; Kobe City Medical Center West Hospital, Japan.
  • Ohnishi H; Akashi Medical Center, Japan.
  • Morita S; Kyoto University School of Medicine, Japan.
  • Hatachi Y; Takarazuka City Hospital, Japan.
Lung Cancer ; 182: 107261, 2023 08.
Article en En | MEDLINE | ID: mdl-37307753
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article